Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Bishop Hans Edgar Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Granted 6,925 shares @ $0
07/06/2023 4 Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Granted 4,152 shares @ $0
06/09/2023 4 Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Granted 65,000 options to buy @ $6.7, valued at $435.5k
04/06/2023 4 Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Granted 7,716 shares @ $0
03/20/2023 4 Bishop Hans Edgar (Director) has filed a Form 4 on AGILENT TECHNOLOGIES, INC.
Txns: Granted 1,658 shares @ $136.82, valued at $226.8k
Granted 741 shares @ $136.82, valued at $101.4k
01/06/2023 4 Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Granted 6,702 shares @ $0
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/09/2022 4 Bishop Hans Edgar (Director) has filed a Form 4 on Lyell Immunopharma, Inc.
Txns: Exercised 145,380 options to buy @ $0.1, valued at $14.5k
07/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/06/2022 4 Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Granted 2,880 shares @ $0
03/21/2022 4 Bishop Hans Edgar (Director) has filed a Form 4 on AGILENT TECHNOLOGIES, INC.
Txns: Granted 1,785 shares @ $136.82, valued at $244.2k
Granted 797 shares @ $136.82, valued at $109k
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
03/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/10/2021 4 Bishop Hans Edgar (Director) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Converted 2,031,250 shares @ $0
Converted 1,075,000 convertible preferred @ $0
Converted 800,000 convertible preferred @ $0
Converted 156,250 convertible preferred @ $0
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
08/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2020 4 Bishop Hans Edgar (Director) has filed a Form 4 on AGILENT TECHNOLOGIES, INC.
Txns: Granted 3,081 shares @ $73.009, valued at $224.9k
Granted 1,027 shares @ $73.009, valued at $75k
11/22/2019 4 Bishop Hans Edgar (Director) has filed a Form 4 on CELGENE CORP /DE/
Txns: Disposed/sold 23,088 shares @ $0
Disposed/sold 10,000 options to buy @ $91.01, valued at $910.1k
Disposed/sold 13,266 options to buy @ $77.38, valued at $1M
Disposed/sold 1,454 restricted stock units @ $0
Disposed/sold 4,756 restricted stock units @ $0
06/05/2019 4 Bishop Hans Edgar (Director) has filed a Form 4 on CELGENE CORP /DE/
Txns: Granted 4,756 restricted stock units @ $0
03/22/2019 4 Bishop Hans Edgar (Director) has filed a Form 4 on AGILENT TECHNOLOGIES INC
Txns: Granted 2,823 shares @ $82, valued at $231.5k
Granted 627 shares @ $82, valued at $51.4k
06/15/2018 4 Bishop Hans Edgar (Director) has filed a Form 4 on CELGENE CORP /DE/
Txns: Granted 13,266 options to buy @ $77.38, valued at $1M
Granted 1,454 restricted stock units @ $0
04/19/2018 3 Bishop Hans Edgar (Director) has filed a Form 3 on CELGENE CORP /DE/
03/23/2018 4 Bishop Hans Edgar (Director) has filed a Form 4 on AGILENT TECHNOLOGIES INC
Txns: Granted 2,876 shares @ $67.47, valued at $194k
Granted 1,438 shares @ $67.47, valued at $97k
03/07/2018 4 Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Unknown transaction of 2,263,948 shares @ $87, valued at $197M
Disposed/sold 48,829 shares @ $87, valued at $4.2M
Disposed/sold 33,133 shares @ $0
Disposed/sold 66,426 shares @ $0
Disposed/sold 35,893 shares @ $0
Disposed/sold 451,756 options to buy @ $6.36, valued at $2.9M
Disposed/sold 140,000 options to buy @ $48.06, valued at $6.7M
Disposed/sold 200,000 options to buy @ $24.5, valued at $4.9M
Disposed/sold 205,823 options to buy @ $20.76, valued at $4.3M
02/09/2018 4 Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Paid exercise price by delivering 4,346 shares @ $85.49, valued at $371.5k
Gifted 116,280 shares @ $0
02/02/2018 4 Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Granted 66,426 shares @ $0
01/18/2018 4 Bishop Hans Edgar (CEO & President) has filed a Form 4 on Juno Therapeutics, Inc.
Txns: Sold 65,820 shares @ $44.7163, valued at $2.9M
Sold 89,888 shares @ $45.5321, valued at $4.1M
Sold 49,082 shares @ $46.5247, valued at $2.3M
Sold 23,003 shares @ $47.6925, valued at $1.1M
Sold 42,457 shares @ $48.5648, valued at $2.1M
Exercised 245,750 options to buy @ $6.36, valued at $1.6M
10/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy